These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 25192691

  • 21. Severe hyperkalaemia with normal electrocardiogram.
    Bandyopadhyay S, Banerjee S.
    Int J Clin Pract; 2001 Sep; 55(7):486-7. PubMed ID: 11594262
    [Abstract] [Full Text] [Related]

  • 22. Persistent hyperkalaemia.
    Xu B, Murray M.
    Aust Fam Physician; 2009 May; 38(5):307-9. PubMed ID: 19458800
    [Abstract] [Full Text] [Related]

  • 23. Thrombocytosis and hyperkalemia revisited.
    Fort JA.
    Am J Pediatr Hematol Oncol; 1989 May; 11(3):334-6. PubMed ID: 2782564
    [Abstract] [Full Text] [Related]

  • 24. Serum potassium in stage 5 CKD patients on their first presentation in a dialysis service of a county hospital in western Romania.
    Gluhovschi G, Mateş A, Gluhovschi C, Golea O, Gădălean F, Somai M, Ene I, Petrica L, Velciov S.
    Rom J Intern Med; 2014 May; 52(1):30-8. PubMed ID: 25000676
    [Abstract] [Full Text] [Related]

  • 25. Leaky cell syndrome: a rare cause of pseudohyperkalaemia.
    Lukens MV, de Mare A, Kerbert-Dreteler MJ, van den Bergh FA.
    Ann Clin Biochem; 2012 Jan; 49(Pt 1):97-100. PubMed ID: 22042978
    [Abstract] [Full Text] [Related]

  • 26. A case of undiagnosed pseudohyperkalaemia following a splenectomy.
    Grech M.
    Age Ageing; 2018 Sep 01; 47(5):758-759. PubMed ID: 29757348
    [Abstract] [Full Text] [Related]

  • 27. Ambient temperature and pseudohyperkalaemia.
    Preiss D, Gunn I.
    Ann Clin Biochem; 2006 Jul 01; 43(Pt 4):326-7. PubMed ID: 16824288
    [No Abstract] [Full Text] [Related]

  • 28. Not all unexplained hyperkalaemia is pseudohyperkalaemia.
    Dimeski G, Dastagir N, Kruger PS, Venkatesh B.
    Crit Care Resusc; 2009 Sep 01; 11(3):219-21. PubMed ID: 19737126
    [Abstract] [Full Text] [Related]

  • 29. Epistaxis: are temperature and seasonal variations true factors in incidence?
    Bray D, Giddings CE, Monnery P, Eze N, Lo S, Toma AG.
    J Laryngol Otol; 2005 Sep 01; 119(9):724-6. PubMed ID: 16156915
    [Abstract] [Full Text] [Related]

  • 30. Pseudohyperkalaemia in thrombocythaemia.
    Wulkan RW, Michiels JJ.
    J Clin Chem Clin Biochem; 1990 Jul 01; 28(7):489-91. PubMed ID: 2230668
    [Abstract] [Full Text] [Related]

  • 31. The potential role of the eGFR in differentiating between true and pseudohyperkalaemia.
    Morris TG, Lamba S, Fitzgerald T, Roulston G, Johnstone H, Mirzazadeh M.
    Ann Clin Biochem; 2020 Nov 01; 57(6):444-455. PubMed ID: 33016076
    [Abstract] [Full Text] [Related]

  • 32. How to minimise factitious hyperkalaemia in blood samples from general practice.
    Johnston JD, Hawthorne SW.
    BMJ; 1997 Apr 19; 314(7088):1200-1. PubMed ID: 9146413
    [No Abstract] [Full Text] [Related]

  • 33. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA, McClure DL, Simon SR, Chan KA, Feldstein A, Andrade SE, Lafata JE, Roblin D, Davis RL, Gunter MJ, Platt R.
    Pharmacoepidemiol Drug Saf; 2007 Jan 19; 16(1):55-64. PubMed ID: 16470693
    [Abstract] [Full Text] [Related]

  • 34. Onset time of hyperkalaemia after angiotensin receptor blocker initiation: when should we start serum potassium monitoring?
    Park IW, Sheen SS, Yoon D, Lee SH, Shin GT, Kim H, Park RW.
    J Clin Pharm Ther; 2014 Feb 19; 39(1):61-8. PubMed ID: 24262001
    [Abstract] [Full Text] [Related]

  • 35. A multidisciplinary approach to reducing spurious hyperkalemia in hospital outpatient clinics.
    Loh TP, Sethi SK.
    J Clin Nurs; 2015 Oct 19; 24(19-20):2900-6. PubMed ID: 26178863
    [Abstract] [Full Text] [Related]

  • 36. Factitious hyperkalemia in hematologic disorders.
    Lábadi Á, Nagy Á, Szomor Á, Miseta A, Kovács GL.
    Scand J Clin Lab Invest; 2017 Feb 19; 77(1):66-72. PubMed ID: 27739333
    [No Abstract] [Full Text] [Related]

  • 37. Pseudohyperkalaemia is a common finding in myeloproliferative disorders that may lead to inappropriate management of patients.
    Ong YL, Deore R, El-Agnaf M.
    Int J Lab Hematol; 2010 Feb 19; 32(1 Pt 1):e151-7. PubMed ID: 19016918
    [Abstract] [Full Text] [Related]

  • 38. Reverse pseudohyperkalemia in heparin plasma samples from a patient with chronic lymphocytic leukemia.
    Meng QH, Krahn J.
    Clin Biochem; 2011 Jun 19; 44(8-9):728-30. PubMed ID: 21406192
    [Abstract] [Full Text] [Related]

  • 39. Pseudohyperkalaemia associated with leukaemic cell lysis during pneumatic tube transport of blood samples.
    Dickinson H, Webb NJ, Chaloner C, Wynn RF, Bonney DK.
    Pediatr Nephrol; 2012 Jun 19; 27(6):1029-31. PubMed ID: 22366875
    [Abstract] [Full Text] [Related]

  • 40. [Pseudohyperkalemia in the serum in reactive thrombocytosis and thrombocythemia].
    Mödder B, Meuthen I.
    Dtsch Med Wochenschr; 1986 Feb 28; 111(9):329-32. PubMed ID: 3948731
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.